National Institute of Child Health and Human Development (NICHD)

Year	Article	Times Cited	Times Cited (no self-citations)
2002	Dimitriadis EK, Horkay F, Maresca J, Kachar B, Chadwick RS. Determination of elastic moduli of thin layers of soft material using the atomic force microscope. Biophys J. May 2002;82(5):2798-2810.	35	35
2020	Mumm S, Gottesman GS, Wenkert D, Campeau PM, Nenninger A, Huskey M, Bijanki VN, Veis DJ, Barnes AM, Marini JC, Stolina M, Zhang F, McAlister WH, Whyte MP. Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation. Bone. January 2020;130:115047.	2	0
2020	Chu EY, Vo TD, Chavez MB, Nagasaki A, Mertz EL, Nociti FH, Aitken SF, Kavanagh D, Zimmerman K, Li X, Stabach PR, Braddock DT, Millán JL, Foster BL, Somerman MJ. Genetic and pharmacologic modulation of cementogenesis via pyrophosphate regulators. Bone. July 2020;136:115329.	2	0
2020	Jacobson DL, Yu W, Hazra R, Brummel S, Geffner ME, Patel K, Borkowsky W, Wang J, Chen JS, Mirza A, DiMeglio LA; Pediatric HIV/AIDS Cohort Study. Fractures in children and adolescents living with perinatally acquired HIV. Bone. October 2020;139:115515.	0	0
2020	Zemel BS, Wasserman H, Kelly A, Fan B, Shepherd J, Lappe J, Gilsanz V, Oberfield S, Winer KK, Kalkwarf HJ. Intermachine differences in DXA measurements vary by skeletal site, and impact the assessment of low bone density in children. Bone. December 2020;141:115581.	1	1
2021	Winer KK, Ye S, Ferré EM, Schmitt MM, Zhang B, Cutler GB Jr, Lionakis MS. Therapy with PTH 1–34 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27 years at a single tertiary care center. Bone. August 2021;149:115977.	5	3
2021	Gladding A, Szymczuk V, Auble BA, Boyce AM. Burosumab treatment for fibrous dysplasia. Bone. September 2021;150:116004.	0	0
2022	Hedjazi G, Guterman-Ram G, Blouin S, Schemenz V, Wagermaier W, Fratzl P, Hartmann MA, Zwerina J, Fratzl-Zelman N, Marini JC. Alterations of bone material properties in growing Ifitm5/BRIL p.s42 knock-in mice, a new model for atypical type vi osteogenesis imperfecta. Bone. September 2022;162:116451.	1	0
2024	He CY, Lee DJ, Foster KL, Gordon CM. Impact of ovarian insufficiency on bone health in childhood cancer survivors: two cases. Bone. January 2024;178:116930.	0	0
2021	Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT. Tumor-induced osteomalacia. Calcif Tiss Int. January 2021;108(1):128-142.	3	2
2001	Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den J Ende, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet. March 1, 2001;10(5):537-543.	72	71
2004	Kozloff KM, Carden A, Bergwitz C, Forlino A, Uveges TE, Morris MD, Marini JC, Goldstein SA. Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J Bone Miner Res. April 2004;19(4):614-622.	29	17
2011	Khosla S, Bellido TM, Drezner MK, Gordon CM, Harris TB, Kiel DP, Kream BE, LeBoff MS, Lian JB, Peterson CA, Rosen CJ, Williams JP, Winer KK, Sherman SS. Forum on aging and skeletal health: summary of the proceedings of an ASBMR workshop. J Bone Miner Res. November 2011;26(11):2565-2578.	1	1
2015	Jha S, Wang Z, Laucis N, Bhattacharyya T. Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996–2012: an ecological analysis. J Bone Miner Res. December 2015;30(12):2179-2187.	22	22
2019	Marx SJ, Goltzman D. Evolution of our understanding of the hyperparathyroid syndromes: a historical perspective. J Bone Miner Res. January 2019;34(1):22-37.	1	1
2019	Kelly A, Shults J, Mostoufi‐Moab S, McCormack SE, Stallings VA, Schall JI, Kalkwarf HJ, Lappe JM, Gilsanz V, Oberfield SE, Shepherd JA, Winer KK, Leonard MB, Zemel BS. Pediatric bone mineral accrual Z‐score calculation equations and their application in childhood disease. J Bone Miner Res. January 2019;34(1):195-203.	0	0
2021	Das A, Wang X, Kang J, Coulter A, Shetty AC, Bachu M, Brooks SR, Dell'Orso S, Foster BL, Fan X, Ozato K, Somerman MJ, Thumbigere‐Math V. Monocyte subsets with high osteoclastogenic potential and their epigenetic regulation orchestrated by IRF8. J Bone Miner Res. January 2021;36(1):199-214.	2	2
2021	Roszko KL, Brown S, Pang Y, Huynh T, Zhuang Z, Pacak K, Collins MT. C‐terminal, but not intact, FGF23 and EPO are strongly correlatively elevated in patients with gain‐of‐function mutations in HIF2A: clinical evidence for EPO regulating FGF23. J Bone Miner Res. February 2021;36(2):315-321.	2	1
2022	Kalkwarf HJ, Shepherd JA, Hans D, Rodriguez EG, Kindler JM, Lappe JM, Oberfield S, Winer KK, Zemel BS. Trabecular bone score reference values for children and adolescents according to age, sex, and ancestry. J Bone Miner Res. April 2022;37(4):776-785.	1	1
2022	Kang H, Aryal AC S, Barnes AM, Martin A, David V, Crawford SE, Marini JC. Antagonism between PEDF and TGF-β contributes to type VI osteogenesis imperfecta bone and vascular pathogenesis. J Bone Miner Res. May 2022;37(5):925-937.	1	0
2022	Szymczuk V, Taylor J, Michel Z, Sinaii N, Boyce AM. Skeletal disease acquisition in fibrous dysplasia: natural history and indicators of lesion progression in children. J Bone Miner Res. August 2022;37(8):1473-1478.	3	1
2022	Hartley IR, Gafni RI, Roszko KL, Brown SM, de Castro LF, Saikali A, Ferreira CR, Gahl WA, Pacak K, Blau JE, Boyce AM, Salusky IB, Collins MT, Florenzano P. Determination of FGF23 levels for the diagnosis of FGF23-mediated hypophosphatemia. J Bone Miner Res. November 2022;37(11):2174-2185.	0	0
2022	Van Uum S, Shrayyef M, M'Hiri I, Dandurand K, Ali DS, Bilezikian JP, Collins MT, Mannstadt M, Rubin MR, Siggelkow H, Tabacco G, Tay Y-KD, Vokes T, Winer KK, Yao L, Guyatt G, Rejnmark L, Khan AA. Initial assessment and monitoring of patients with chronic hypoparathyroidism: a systematic current practice survey. J Bone Miner Res. December 2022;37(12):2630-2641.	4	0
2022	Khan AA, Guyatt G, Ali DS, Bilezikian JP, Collins MT, Dandurand K, Mannstadt M, Murphy D, M'Hiri I, Rubin MR, Sanders R, Shrayyef M, Siggelkow H, Tabacco G, Tay Y-KD, Van Uum S, Vokes T, Winer KK, Yao L, Rejnmark L. Management of hypoparathyroidism. J Bone Miner Res. December 2022;37(12):2663-2677.	5	0
2023	Pan KS, Taylor J, Szymczuk V, Boyce AM. Lesion expansion in gnathic fibrous dysplasia: natural history, indicators of progression, and response to bisphosphonates. J Bone Miner Res. October 2023;38(10):1465-1471.	0	0
2011	Zemel BS, Kalkwarf HJ, Gilsanz V, Lappe JM, Oberfield S, Shepherd JA, Frederick MM, Huang X, Lu M, Mahboubi S, Hangartner T, Winer KK. Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab. October 2011;96(10):3160-3169.	23	17
2016	Forlino A, Marini JC. Osteogenesis imperfecta. Lancet. April 16, 2016;387(10028):1657-1671.	41	40

Name	Count	Oldest	Newest
Gordon, Catherine M.	1	2024	2024
Marini, Joan Carol	5	2004	2022
Forlino, Antonella	1	2004	2004
Winer, Karen K.	8	2011	2022